229 related articles for article (PubMed ID: 24592237)
1. Hijacking PrP(c)-dependent signal transduction: when prions impair Aβ clearance.
Hernandez-Rapp J; Martin-Lannerée S; Hirsch TZ; Launay JM; Mouillet-Richard S
Front Aging Neurosci; 2014; 6():25. PubMed ID: 24592237
[TBL] [Abstract][Full Text] [Related]
2. PrP(C) signalling in neurons: from basics to clinical challenges.
Hirsch TZ; Hernandez-Rapp J; Martin-Lannerée S; Launay JM; Mouillet-Richard S
Biochimie; 2014 Sep; 104():2-11. PubMed ID: 24952348
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic prions deviate PrP(C) signaling in neuronal cells and impair A-beta clearance.
Pradines E; Hernandez-Rapp J; Villa-Diaz A; Dakowski C; Ardila-Osorio H; Haik S; Schneider B; Launay JM; Kellermann O; Torres JM; Mouillet-Richard S
Cell Death Dis; 2013 Jan; 4(1):e456. PubMed ID: 23303130
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
5. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Control of the Notch and Eph Signaling Pathways by the Prion Protein: Implications for Prion Diseases.
Hirsch TZ; Martin-Lannerée S; Reine F; Hernandez-Rapp J; Herzog L; Dron M; Privat N; Passet B; Halliez S; Villa-Diaz A; Lacroux C; Klein V; Haïk S; Andréoletti O; Torres JM; Vilotte JL; Béringue V; Mouillet-Richard S
Mol Neurobiol; 2019 Mar; 56(3):2159-2173. PubMed ID: 29998397
[TBL] [Abstract][Full Text] [Related]
7. PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.
Pietri M; Dakowski C; Hannaoui S; Alleaume-Butaux A; Hernandez-Rapp J; Ragagnin A; Mouillet-Richard S; Haik S; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
Nat Med; 2013 Sep; 19(9):1124-31. PubMed ID: 23955714
[TBL] [Abstract][Full Text] [Related]
8. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
9. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
10. Soluble Aβ aggregates can inhibit prion propagation.
Sarell CJ; Quarterman E; Yip DC; Terry C; Nicoll AJ; Wadsworth JDF; Farrow MA; Walsh DM; Collinge J
Open Biol; 2017 Nov; 7(11):. PubMed ID: 29142106
[TBL] [Abstract][Full Text] [Related]
11. Cellular prion protein signaling in serotonergic neuronal cells.
Mouillet-Richard S; Schneider B; Pradines E; Pietri M; Ermonval M; Grassi J; Richards JG; Mutel V; Launay JM; Kellermann O
Ann N Y Acad Sci; 2007 Jan; 1096():106-19. PubMed ID: 17405922
[TBL] [Abstract][Full Text] [Related]
12. Identification of PrP sequences essential for the interaction between the PrP polymers and Aβ peptide in a yeast-based assay.
Rubel AA; Ryzhova TA; Antonets KS; Chernoff YO; Galkin A
Prion; 2013; 7(6):469-76. PubMed ID: 24152606
[TBL] [Abstract][Full Text] [Related]
13. Activation of zebrafish Src family kinases by the prion protein is an amyloid-β-sensitive signal that prevents the endocytosis and degradation of E-cadherin/β-catenin complexes in vivo.
Sempou E; Biasini E; Pinzón-Olejua A; Harris DA; Málaga-Trillo E
Mol Neurodegener; 2016 Feb; 11():18. PubMed ID: 26860872
[TBL] [Abstract][Full Text] [Related]
14. Prion protein oligomer and its neurotoxicity.
Huang P; Lian F; Wen Y; Guo C; Lin D
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632
[TBL] [Abstract][Full Text] [Related]
15. Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity.
Black SA; Stys PK; Zamponi GW; Tsutsui S
Front Cell Dev Biol; 2014; 2():45. PubMed ID: 25364752
[TBL] [Abstract][Full Text] [Related]
16. Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep.
Lim K; Kim SY; Lee B; Segarra C; Kang S; Ju Y; Schmerr MJ; Coste J; Kim SY; Yokoyama T; An SS
Int J Nanomedicine; 2015; 10(Spec Iss):241-50. PubMed ID: 26425091
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of neurotoxicity of pathological prion protein.
Castilla J; Hetz C; Soto C
Curr Mol Med; 2004 Jun; 4(4):397-403. PubMed ID: 15354870
[TBL] [Abstract][Full Text] [Related]
18. Overstimulation of PrPC signaling pathways by prion peptide 106-126 causes oxidative injury of bioaminergic neuronal cells.
Pietri M; Caprini A; Mouillet-Richard S; Pradines E; Ermonval M; Grassi J; Kellermann O; Schneider B
J Biol Chem; 2006 Sep; 281(38):28470-9. PubMed ID: 16864581
[TBL] [Abstract][Full Text] [Related]
19. Generating Bona Fide Mammalian Prions with Internal Deletions.
Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
[TBL] [Abstract][Full Text] [Related]
20. Profiling the culprit in Alzheimer's disease (AD): bacterial toxic proteins - Will they be significant for the aetio-pathogenesis of AD and the transmissible spongiform encephalopathies?
Schmitt HP
Med Hypotheses; 2007; 69(3):596-609. PubMed ID: 17337124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
